Skip to main content
. 2020 Aug 6;7(10):ofaa319. doi: 10.1093/ofid/ofaa319

Table 1.

Baseline Patients Characteristics on Admission

Total Supportive Care Remdesivir
n = 224 n = 125 n = 99 P Value
Age 59.00 (50.00–68.00) 60.00 (50.00–68.00) 58.00 (50.00–68.00) .52
Gender .44
 Female 74 (33.0) 44 (35.2) 30 (30.3)
 Male 150 (67.0) 81 (64.8) 69 (69.7)
Race .65
 Asian 2 (0.9) 1 (0.8) 1 (1.0)
 Black or African American 30 (13.4) 20 (16.0) 10 (10.1)
 Hispanic or Latino 98 (43.8) 50 (40.0) 48 (48.5)
 Other/unknown 12 (5.4) 7 (5.6) 5 (5.1)
 White or Caucasian 82 (36.6) 47 (37.6) 35 (35.4)
Hypertension 87 (38.8) 55 (44.0) 32 (32.3) .075
Heart disease 49 (21.9) 35 (28.0) 14 (14.1) .013
Chronic pulmonary disease 26 (11.6) 15 (12.0) 11 (11.1) .84
Diabetes 60 (26.8) 32 (25.6) 28 (28.3) .65
Renal failure 10 (4.5) 7 (5.6) 3 (3.0) .36
Liver disease 9 (4.0) 5 (4.0) 4 (4.0) .99
Obesity 103 (46.0) 60 (48.0) 43 (43.4) .50
Days from symptoms onset 6.00 (3.00–8.00) 6.00 (2.00–7.00) 6.00 (3.00–8.00) .59
Baseline oxygen .75
 Invasive mechanical ventilation 43 (19.5) 24 (19.7) 19 (19.2)
 Low-flow supplemental oxygen 108 (48.9) 60 (49.2) 48 (48.5)
 NIPPV or HFOD 55 (24.9) 28 (23.0) 27 (27.3)
 Room air 15 (6.8) 10 (8.2) 5 (5.1)
Corticosteroidsa 61 (27.2) 34 (27.2) 27 (27.3) .99
Hydroxychloroquine 25 (11.2) 20 (16.0) 5 (5.1) .010
Convalescent plasma 19 (8.5) 16 (12.8) 3 (3.0) .009
Weighted Elixhauser index (van Walraven) .009
 <0 53 (23.7) 24 (19.2) 29 (29.3)
 0 61 (27.2) 27 (21.6) 34 (34.3)
 1–4 30 (13.4) 21 (16.8) 9 (9.1)
 ≥5 80 (35.7) 53 (42.4) 27 (27.3)

Bold values: P < 0.05. Data are presented as No. (%) or median (interquartile range). Comorbidities were estimated using ICD-10 codes according to the Elixhauser Comorbidity Index.

Abbreviations: HFOD, high-flow oxygen devices; ICD-10, International Classification of Diseases, 10th Revision; NIPPV, noninvasive positive pressure ventilation.

aAt least 1 dose of dexamethasone, fludrocortisone, hydrocortisone, methylprednisolone, or prednisone.